US Patent 7511159 Azetidine ring compounds and drugs comprising the same
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+141 characters)
Article
Patent abstract
It is intended to provide compounds having EDG-5 antagonism. Because of having EDG-5 antagonism, compounds of the formula (I):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07511159 Azetidine ring compounds and drugs comprising the same US Patent 7511159 Azetidine ring compounds and drugs comprising the same
Infobox
Patent Number
0751115900
Patent Number
751115900
Edits on 21 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075111590
Date of Patent
March 31, 2009
0Patent Application Number
105844350
Date Filed
December 24, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075111590
Date of Patent
March 31, 2009
0Patent Application Number
105844350
Date Filed
December 24, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07511159 Azetidine ring compounds and drugs comprising the same
Infobox
Is a
Patent jurisdiction
Patent number
07511159
Date of patent
March 31, 2009
Patent application number
10584435
Date Filed
December 24, 2004
Patent primary examiner
Find more entities like US Patent 7511159 Azetidine ring compounds and drugs comprising the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
